DW14006 as a direct AMPK alpha 1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation | |
Lv, Jianlu1; Wang, Wei2,3; Zhu, Xialin1; Xu, Xiaoju1; Yan, Qiuying1; Lu, Jian1; Shi, Xiaofan1,2; Wang, Zhengyu4; Zhou, Jinpei4; Huang, Xi1 | |
刊名 | BRAIN BEHAVIOR AND IMMUNITY |
2020-11-01 | |
卷号 | 90页码:55-69 |
关键词 | Alzheimer'sdisease Microglia AMPK alpha 1 DW14006 Phagocytosis Neuro-inflammation |
ISSN号 | 0889-1591 |
DOI | 10.1016/j.bbi.2020.07.041 |
通讯作者 | Wang, Jiaying(wangjy@njucm.edu.cn) ; Duan, Wenhu(whduan@simm.ac.cn) ; Shen, Xu(xshen@njucm.edu.cn) |
英文摘要 | Alzheimer's disease (AD) is a progressively neurodegenerative disease with typical hallmarks of amyloid beta (A beta) plaque accumulation, neurofibrillary tangle (NFT) formation and neuronal death extension. In AD brain, activated microglia phagocytose A beta and neuronal debris, but also aggravate inflammation stress by releasing inflammatory factors and cytotoxins. Improving microglia on A beta catabolism and neuroinflammatory intervention is thus believed to be a promising therapeutic strategy for AD. AMP-activated protein kinase (AMPK) is highly expressed in microglia with AMPK alpha 1 being tightly implicated in neuroinflammatory events. Since indirect AMPK alpha 1 activators may cause side effects with undesired intracellular AMP/ATP ratio, we focused on direct AMPK alpha 1 activator study by exploring its potential function in ameliorating AD-like pathology of AD model mice. Here, we reported that direct AMPK alpha 1 activator DW14006 (2-(3-(7-chloro-6-(2 '-hydroxy-[1,1 '-biphenyl]-4-yl)2-oxo-1,2-dihydroquinolin-3-yl)phenyl)acetic acid) effectively improved learning and memory impairments of APP/PS1 mice, and the underlying mechanisms have been intensively investigated. DW14006 reduced amyloid plaque deposition by promoting microglial o-A beta 42 phagocytosis and ameliorated innate immune response by polarizing microglia to an anti-inflammatory phenotype. It selectively enhanced microglial phagocytosis of oA beta 42 by upgrading scavenger receptor CD36 through AMPK alpha 1/PPAR gamma/CD36 signaling and suppressed inflammation by AMPK alpha 1/I kappa B/NF kappa B signaling. Together, our work has detailed the crosstalk between AMPK alpha 1 and microglia in AD model mice, and highlighted the potential of DW14006 in the treatment of AD. |
资助项目 | National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China[2018ZX09711002] ; National Natural Science Foundation for Young Scientists of China[81703806] ; Postgraduate Research & Practice Innovation Program of Jiangsu Province[KYCX18_1600] ; Open Project Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica[JKLPSE201801] ; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) ; Priority Academic Program Development of Jiangsu Higher Education Institutions (Integration of Chinese and Western Medicine) ; Innovative Research Team of Six Talent Peaks Project in Jiangsu Province[TD-SWYY-013] |
WOS关键词 | NF-KAPPA-B ; AMELIORATES MEMORY IMPAIRMENT ; PROTEIN-KINASE ACTIVATION ; ALZHEIMERS-DISEASE MODEL ; ADENOSINE-MONOPHOSPHATE ; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE ; HUMAN MONOCYTES ; DOWN-REGULATION ; MOUSE MODEL ; BETA |
WOS研究方向 | Immunology ; Neurosciences & Neurology ; Psychiatry |
语种 | 英语 |
出版者 | ACADEMIC PRESS INC ELSEVIER SCIENCE |
WOS记录号 | WOS:000577976900006 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/291370] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Wang, Jiaying; Duan, Wenhu; Shen, Xu |
作者单位 | 1.Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing 210023, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Med Chem, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China 3.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China 4.China Pharmaceut Univ, Dept Med Chem, 24 Tongjia Xiang, Nanjing 210009, Peoples R China |
推荐引用方式 GB/T 7714 | Lv, Jianlu,Wang, Wei,Zhu, Xialin,et al. DW14006 as a direct AMPK alpha 1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation[J]. BRAIN BEHAVIOR AND IMMUNITY,2020,90:55-69. |
APA | Lv, Jianlu.,Wang, Wei.,Zhu, Xialin.,Xu, Xiaoju.,Yan, Qiuying.,...&Shen, Xu.(2020).DW14006 as a direct AMPK alpha 1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.BRAIN BEHAVIOR AND IMMUNITY,90,55-69. |
MLA | Lv, Jianlu,et al."DW14006 as a direct AMPK alpha 1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation".BRAIN BEHAVIOR AND IMMUNITY 90(2020):55-69. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论